maccura(SZ:300463) Sou Hu Cai Jing·2025-05-26 09:47Group 1 - The core viewpoint of the news highlights that Maike Biological's stock closed at 11.55 yuan, down 1.70%, with a rolling PE ratio of 233.14 times, and a total market value of 7.074 billion yuan [1] - The average PE ratio for the medical device industry is 48.92 times, with a median of 35.68 times, placing Maike Biological at the 118th position in the industry ranking [1][3] - As of March 31, 2025, the number of shareholders for Maike Biological is 35,022, a decrease of 1,242 from the previous count, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1] Group 2 - Maike Biological Co., Ltd. specializes in the research, production, sales, and related services of in vitro diagnostic products, with a wide range of testing reagents for various medical conditions [2] - The latest quarterly report for Q1 2025 shows that the company achieved an operating revenue of 510 million yuan, a year-on-year decrease of 17.22%, and a net profit of 23.98 million yuan, down 80.09% year-on-year, with a gross profit margin of 56.76% [2]